Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) ROA

ADMA BIOLOGICS, INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • ADMA BIOLOGICS, INC. roa for the quarter ending 2026-06-30 was 24.69%, a 34.00% decline year-over-year.
  • ADMA BIOLOGICS, INC. roa for the quarter ending 2026-03-31 was 24.86%, a 38.62% decline year-over-year.
  • ADMA BIOLOGICS, INC. roa for the quarter ending 2025-12-31 was 23.54%, a 41.81% decline year-over-year.
  • ADMA BIOLOGICS, INC. roa for the quarter ending 2025-09-30 was 36.83%, a 111.16% increase year-over-year.
  • ADMA BIOLOGICS, INC. roa for fiscal 2025 was 23.54%, a 41.81% decline from fiscal 2024.
  • ADMA BIOLOGICS, INC. roa for fiscal 2024 was 40.45%, a change of 49.03% from fiscal 2023.
  • ADMA BIOLOGICS, INC. roa for fiscal 2023 was -8.58%, a change of 10.33% from fiscal 2022.
  • ADMA BIOLOGICS, INC. roa for fiscal 2022 was -18.91%, a change of 7.02% from fiscal 2021.
Available history
2011-06-30 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-3024.69%$168.96M$37.82M$684.21M
2026-03-3124.86%$165.35M$45.33M$665.18M
2025-12-3123.54%$146.93M$49.38M$624.24M
2025-09-3036.83%$209.45M$36.43M$568.69M
2025-06-3037.42%$208.93M$34.22M$558.38M
2025-03-3140.50%$206.77M$26.90M$510.57M
2024-12-3140.45%$197.67M$111.92M$488.68M
2024-09-3017.44%$68.13M$35.91M$390.62M
2024-06-309.24%$34.79M$32.06M$376.4M
2024-03-31-1.04%-$3.65M$17.81M$350.88M
2023-12-31-8.58%-$28.24M-$17.61M$329.18M
2023-09-30-6.54%-$22.83M$2.56M$349M
2023-06-30-11.75%-$40.29M-$6.37M$343.03M
2023-03-31-13.99%-$47.69M-$6.79M$340.79M
2022-12-31-18.91%-$65.9M-$12.23M$348.46M
2022-09-30-23.40%-$70.32M-$14.90M$300.56M
2022-06-30-24.63%-$73.14M-$13.76M$296.93M
2022-03-31-25.41%-$78.28M-$25.01M$308.03M
2021-12-31-25.94%-$71.65M-$16.65M$276.25M
2021-09-30-31.18%-$74.41M-$17.71M$238.64M
2021-06-30-31.62%-$73.61M-$18.91M$232.81M
2021-03-31-31.78%-$74.88M-$18.38M$235.67M
2020-12-31-36.47%-$75.75M-$19.41M$207.67M
2020-09-30-35.22%-$66.9M-$16.92M$189.98M
2020-06-30-32.07%-$61.42M-$20.18M$191.54M
2020-03-31-25.87%-$54.46M-$19.25M$210.52M
2019-12-31-37.99%-$48.28M-$10.56M$127.09M
2019-09-30-40.47%-$55.76M-$11.44M$137.78M
2019-06-30-41.50%-$59.45M-$13.21M$143.27M
2019-03-31-78.07%-$60.99M-$13.07M$78.12M
2018-12-31-73.97%-$65.74M-$18.04M$88.88M
2018-09-30-57.07%-$60.69M-$15.14M$106.35M
2018-06-30-51.60%-$60.76M-$14.75M$117.75M
2018-03-31-60.40%-$55.04M-$17.82M$91.14M
2017-12-31-40.51%-$43.76M-$12.98M$108.02M
2017-09-30-48.53%-$35.34M-$15.20M$72.81M
2017-06-30-28.90%-$24.46M-$9.04M$84.64M
2017-03-31-121.85%-$21.44M-$6.54M$17.59M
2016-12-31-82.39%-$19.52M-$4.56M$23.69M
2016-09-30-71.06%-$19.54M-$4.33M$27.5M
2016-06-30-63.98%-$20.31M-$6.01M$31.74M
2016-03-31-96.40%-$18.98M-$4.61M$19.68M
2015-12-31-75.78%-$17.97M-$4.58M$23.71M
2015-09-30-60.92%-$16.95M-$5.10M$27.82M
2015-06-30-51.12%-$15.23M-$4.68M$29.8M
2015-03-31-42.78%-$14.51M-$3.61M$33.93M
2014-12-31-62.22%-$16.81M-$3.56M$27.02M
2014-09-30-70.99%-$17.95M-$3.38M$25.29M
2014-06-30-61.88%-$17.26M-$3.96M$27.88M
2014-03-31-56.93%-$18.19M-$5.90M$31.95M
2013-12-31-48.55%-$15.53M-$4.70M$31.98M
2013-09-30-150.28%-$13.08M-$2.69M$8.7M
2013-06-30-127.54%-$13.63M-$4.90M$10.69M
2013-03-31-71.98%-$9.95M-$3.24M$13.82M
2012-12-31-46.94%-$7.3M-$2.25M$15.56M
2012-09-30-45.40%-$6M-$3.25M$13.22M
2012-06-30-23.55%-$3.74M-$1.21M$15.88M
2012-03-31-28.93%-$4.92M-$597.31K$17.01M
2011-12-31-201.76%-$5.9M-$8.33K$2.93M
2011-09-30-83836.55%-$4.95M-$981.08K$5,909.00
2011-06-30-46727.77%-$3.98M-$2.39M$8,512.00

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-3123.54%$146.93M$624.24M
2024-12-3140.45%$197.67M$488.68M
2023-12-31-8.58%-$28.24M$329.18M
2022-12-31-18.91%-$65.9M$348.46M
2021-12-31-25.94%-$71.65M$276.25M
2020-12-31-36.47%-$75.75M$207.67M
2019-12-31-37.99%-$48.28M$127.09M
2018-12-31-73.97%-$65.74M$88.88M
2017-12-31-40.51%-$43.76M$108.02M
2016-12-31-82.39%-$19.52M$23.69M
2015-12-31-75.78%-$17.97M$23.71M
2014-12-31-62.22%-$16.81M$27.02M
2013-12-31-48.55%-$15.53M$31.98M
2012-12-31-46.94%-$7.3M$15.56M
2011-12-31-201.76%-$5.9M$2.93M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43